Cite
HARVARD Citation
Firwana, B. et al. (n.d.). Tyrosine kinase inhibitors as a first‐line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed‐treatment comparison. International journal of cancer. 138 (6), pp. 1545-1553. [Online].